Núñez M - Search Results

1

Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin.

Núñez M, Ocampo A, Aguirrebengoa K, Cervantes M, Pascual A, Echeverria S, Asensi V, Barreiro P, Garcia-Samaniego J, Soriano V; PRESCO Team. Núñez M, et al. J Viral Hepat. 2008 May;15(5):363-9. doi: 10.1111/j.1365-2893.2007.00952.x. Epub 2007 Dec 21. J Viral Hepat. 2008. PMID: 18179454 Clinical Trial.

2

Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin. Caelyx/KS Spanish Study Group.

Núñez M, Machuca A, Soriano V, Podzamczer D, González-Lahoz J. Núñez M, et al. AIDS. 2000 May 26;14(8):913-9. doi: 10.1097/00002030-200005260-00002. AIDS. 2000. PMID: 10853972 Clinical Trial.

3

[Cancer and human immunodeficiency virus in the era of combination therapy].

Núñez M, Soriano V. Núñez M, et al. Med Clin (Barc). 2000 Jun 17;115(3):93-4. doi: 10.1016/s0025-7753(00)71475-8. Med Clin (Barc). 2000. PMID: 10965483 Spanish. No abstract available.

4

Salvage therapy for HIV infection: when and how.

Núñez M, Soriano V. Núñez M, et al. AIDS Patient Care STDS. 2000 Sep;14(9):465-76. doi: 10.1089/108729100438845. AIDS Patient Care STDS. 2000. PMID: 11051629 Review. No abstract available.

5

Performance of a quadruple combination including nelfinavir plus efavirenz in naive subjects with high baseline viral load and in patients failing protease inhibitor-containing regimens.

Barreiro P, Oller V, Soriano V, Nuñez M, Rodríguez-Rosado R, González-Lahoz J. Barreiro P, et al. Among authors: nunez m. J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):391-2. doi: 10.1097/00126334-200104010-00020. J Acquir Immune Defic Syndr. 2001. PMID: 11317086 Clinical Trial. No abstract available.

6

Intensification of antiretroviral therapy.

Núñez M, Rodríguez-Rosado R, Soriano V. Núñez M, et al. AIDS Res Hum Retroviruses. 2001 Apr 10;17(6):499-506. doi: 10.1089/08892220151126544. AIDS Res Hum Retroviruses. 2001. PMID: 11350663 No abstract available.

7

Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy.

Núñez M, Lana R, Mendoza JL, Martín-Carbonero L, Soriano V. Núñez M, et al. J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):426-31. doi: 10.1097/00126334-200108150-00002. J Acquir Immune Defic Syndr. 2001. PMID: 11511818

8

Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy.

Núñez M, Saballs P, Valencia ME, Santos J, Ferrer E, Santos I, Berrocal A, Galindo MJ, Podzamczer D, Gonzlez-Lahoz J; Caelyx/KS Spanish Study Group. Núñez M, et al. HIV Clin Trials. 2001 Sep-Oct;2(5):429-37. doi: 10.1310/700b-9qt3-hgn9-q3fq. HIV Clin Trials. 2001. PMID: 11673818 Clinical Trial.

9

[Acute hepatitis B in a previously vaccinated patient infected by the human immunodeficiency virus].

Díaz B, Núñez M, Soriano V. Díaz B, et al. Among authors: nunez m. Med Clin (Barc). 2001 Oct 27;117(13):518-9. doi: 10.1016/s0025-7753(01)72163-x. Med Clin (Barc). 2001. PMID: 11707213 Spanish. No abstract available.

10

[Rate and risk factors of liver toxicity in patients receiving antiretroviral therapy].

Lana R, Núñez M, Mendoza JL, Soriano V. Lana R, et al. Among authors: nunez m. Med Clin (Barc). 2001 Nov 17;117(16):607-10. doi: 10.1016/s0025-7753(01)72194-x. Med Clin (Barc). 2001. PMID: 11714465 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,739 results

Search Page

Filters